Sign in Create account

Bajaj Healthcare Limited

Healthcare · Pharmaceuticals & Biotechnology

NSE: BAJAJHCARE BSE: 539872
₹327.20
▼ -7.80 (-2.33%)
Sept. 30, 2026 · NSE · nse_bhavcopy
Quality
46/100
Moderate
Valuation
39/100
Fairly Valued
Momentum
15/100
Bearish

QVM read Mixed signals Quality Moderate, Valuation Fairly Valued, Momentum Bearish

Tradinity's own scoring, not a copy of any third party's -- see the Key Metrics section for the real ratios behind each number.

Key Metrics

Market Capitalization
₹1,101 Cr
PE (TTM)
46.1
Industry median 36.1 (152 companies)
Price to Book
2.1
PEG (TTM)
-0.9
Institutions holding %
4.11%
FII + DII, latest filed period
Piotroski Score
6
Relative return vs Nifty50, qtr %
1.9
Relative return vs Sector, qtr %
-5.2
Free Cash Flow
₹15 Cr
as of March 31, 2026
Industry median ₹-0 Cr (198 companies)
EPS Growth (YoY)
7.27%
as of June 30, 2026
Industry median 26.14% (180 companies)
Net Profit Growth (TTM)
0.00%
as of June 30, 2026
Industry median 6.21% (175 companies)
Operating Revenue Growth (TTM)
12.27%
as of June 30, 2026
Industry median 9.08% (175 companies)
Profit Growth (YoY)
-79.44%
as of March 31, 2023
Industry median 22.20% (176 companies)
Revenue Growth (YoY)
11.28%
as of June 30, 2026
Industry median 14.05% (173 companies)
Current Ratio
1.78
as of March 31, 2026
Industry median 1.84 (197 companies)
Debt to Equity
0.44
as of March 31, 2026
Industry median 0.14 (186 companies)
Interest Coverage
2.34
as of June 30, 2026
Industry median 10.58 (182 companies)
Net Margin
2.27%
as of March 31, 2023
Industry median 9.35% (179 companies)
Operating Margin (EBIT)
13.61%
as of June 30, 2026
Industry median 14.22% (181 companies)
Operating Margin (TTM)
8.59%
as of June 30, 2026
Industry median 12.41% (182 companies)
Return on Assets
4.66%
as of March 31, 2026
Industry median 5.54% (180 companies)
Return on Capital Employed
8.47%
as of March 31, 2026
Industry median 12.43% (181 companies)
Return on Equity
8.07%
as of March 31, 2026
Industry median 9.66% (179 companies)

Investment checklist

Tradinity's own yes/no questions with the rule stated beside each. “Items without enough data are left out, never counted as a No, and the totals count only answered questions. A summary of numbers on this page, not advice.

Financials

3 of 7 met
  • No Revenue is higher than a year earlier in each of the last 4 quarters
  • No Quality score is Strong (70 or more)
  • No Piotroski F-score is 7 or more (score 6)
  • Yes Debt to equity is below 0.5 (0.44)
  • No Return on equity is 15% or more (8.1%)
  • Yes Net cash flow for the latest year is positive
  • Yes Cash from operations is higher than the year before

Ownership

4 of 4 met
  • Yes FII/FPI or DII holding rose in the latest quarter
  • Yes Promoter holding rose or was unchanged in the latest quarter
  • Yes Promoter pledge is 5% of their holding or less and not rising (0.0% pledged)
  • Yes Insiders have not sold in the past 3 months (no open-market sale filed in the last 3 months)

Peer comparison

0 of 3 met
  • No 1-year return beats the industry median
  • No Revenue growth beats the industry median
  • No Profit growth beats the industry median

Value and momentum

0 of 6 met
  • No Price sits in the Buy zone of its own historical PE range (Sell Zone)
  • No Valuation score is Undervalued (70 or more)
  • No Momentum score is Bullish (70 or more)
  • No Price is above the 5, 10 and 20 day averages
  • No Price is above the 50, 100 and 200 day averages
  • No Latest candle has a bullish shape (hammer, dragonfly doji, white marubozu)

Price

Download CSV

PE/EPS use each quarter's real filed EPS only from 45 days after quarter-end (no look-ahead) against the raw close of the day. Price-to-book isn't a mode here: the feed has no dated share count, so there's no real history to chart.

RSI (14) (same adjusted close series as the price chart above)

MACD (12, 26, 9) (same adjusted close series as the price chart above)

Relative Returns (vs NIFTY 50)

Prices adjusted for splits and bonuses. * = a corporate action affecting this date could not be parsed and is not reflected.

Price range

Day return
-2.3%
Low 325.1500 · High 338.0000
1W return
-7.2%
Low 325.1500 · High 364.4000
1M return
-1.9%
Low 313.0500 · High 364.4000
52W return
-31.9%
Low 272.3500 · High 506.4500
Lifetime High ₹712.2000 (March 25, 2025)
Lifetime Low ₹262.4500 (June 20, 2022)

Full price history and technicals →

Technicals

Full technicals, indicators & Volume/Delivery →

EMA & SMA

Bullish0
Bearish6
5D
335.1
10D
335.8
20D
334.0
50D
331.3
100D
332.0
200D
338.6

Delivery and volume

Day avg. delivery
51.0%
Week avg. delivery
51.9%
Month avg. delivery
48.4%

Week = 5 sessions, Month = 22 sessions ending the latest trading day — the same combined NSE+BSE delivery data as the table below, just summed.

Resistance and support

330.12
Pivot
First resistance335.08
Second resistance342.97
Third resistance347.93
First support322.23
Second support317.27
Third support309.38
Day RSI45.6
Day MFI61.5
Day MACD2.29
Day MACD signal2.40

Beta

1M1.45
3M0.86
1Y1.23
3Y1.02

Price change analysis

↓ -1.9%
Over 1 Month
LowHigh
313.05364.40
↓ -5.2%
Over 3 Months
LowHigh
313.05394.00
↑ 5.0%
Over 6 Months
LowHigh
272.35394.00
↓ -31.9%
Over 1 Year
LowHigh
272.35506.45
Legend Positive indicator Neutral indicator Negative indicator

Buy/Sell Zone

View Buy/Sell Zone →
Current PE 46.1 (own history: 25.1–49.5)
Sell Zone

Financials

View full financials, peers & valuation multiples →
Revenue (June 30, 2026)
₹166 Cr
Net profit (June 30, 2026)
₹14 Cr
Basic EPS (June 30, 2026)
₹4.1300

Ranks #89 of 184 in Pharmaceuticals & Biotechnology by market cap -- full peer table on the Financials page.

Shareholding pattern / Ownership

Shareholding summary

Jun 2026
  • Promoter58.59%
  • Mutual funds1.69%
  • FII/FPI2.19%
  • Other DII0.23%
  • Public37.30%

Largest holders

NameCategoryShares %Shares
SAJANKUMAR RAMESHWARLAL BAJAJPromoter36.6200%12325774
ANIL CHAMPALAL JAINPromoter6.0500%2036544
NAMRATA BAJAJPromoter4.8500%1632207
NIHITA BAJAJ KUMARPromoter4.8100%1620360
BABITA SAJANKUMAR BAJAJPromoter4.4700%1504000

As of June 30, 2026. Only holders the filing discloses individually.

Historical promoter holding

Promoters holdings increased from 58.29% to 58.59% in Jun 2026 qtr

Historical fii holding

FII/FPI holdings increased from 1.98% to 2.19% in Jun 2026 qtr

Historical mutual fund holding

Mutual funds holdings were unchanged at 1.69% in Jun 2026 qtr

All shareholding details →

Insider trading, SAST & pledges

All 21 insider trades, 16 SAST, 0 pledge events →

Latest insider trades

FiledPersonCategoryTypeQuantityValue
21 Mar 2026 SAJANKUMAR RAMESHWARLAL BAJAJ Promoter Buy 0 ₹0
21 Mar 2026 ANIL CHAMPALAL JAIN Promoter group Buy 0 ₹0
20 Mar 2026 ANIL CHAMPALAL JAIN Promoter group Buy 0 ₹0
18 Mar 2026 ANIL CHAMPALAL JAIN Promoter group Buy 0 ₹0
18 Mar 2026 ANIL CHAMPALAL JAIN Promoter group Buy 0 ₹0
7 Feb 2025 SKR BAJAJ HUF Promoter group Sell 0 ₹0
7 Feb 2025 SAJANKUMAR RAMESHWARLAL BAJAJ Promoter Buy 0 ₹0
16 Feb 2024 Namrata Bajaj Promoter group Buy 0 ₹0
16 Nov 2023 Anil Champalal Jain Promoter group Buy 0 ₹0
21 Sep 2023 Sajankumar Rameshwarlal Bajaj Promoter Buy 0 ₹0

All insider and SAST disclosures →

Deals (Bulk & Block)

All 174 deals, with filters and CSV →
DateClientDealActionQuantityPriceExchange
22 Jul 2026 WESTSTONE MANAGEMENT CONSULTANCY PRIVATE LIMITED Bulk Sell 200,000 332.9100 NSE
29 Jun 2026 VINSUL MAKARDI LTD Bulk Sell 169,688 348.0700 NSE
29 Jun 2026 VINSUL MAKARDI LTD Bulk Buy 169,688 347.4300 NSE
29 Jun 2026 QE SECURITIES LLP Bulk Buy 527,910 347.8900 NSE
29 Jun 2026 QE SECURITIES LLP Bulk Sell 527,379 345.4800 NSE
29 Jun 2026 NK SECURITIES RESEARCH PRIVATE LIMITED Bulk Sell 723,881 347.1700 NSE
29 Jun 2026 NK SECURITIES RESEARCH PRIVATE LIMITED Bulk Buy 723,881 346.9600 NSE
29 Jun 2026 MICROCURVES TRADING PRIVATE LIMITED Bulk Buy 453,096 347.2700 NSE
29 Jun 2026 MICROCURVES TRADING PRIVATE LIMITED Bulk Sell 453,096 347.5900 NSE
29 Jun 2026 JUNOMONETA FINSOL PRIVATE LIMITED Bulk Sell 476,567 347.9100 NSE

All bulk and block deals →

Dividends

Full dividend history →
Last 12 months ₹1.50 per share
Dividend yield 0.46%
Ex-dateSubjectPer share (₹)Record date
11 Sep 2026 Dividend - Rs 1.50 Per Share 1.5000 14 Sep 2026
19 Sep 2025 Dividend - Re 1 Per Share 1.0000 19 Sep 2025
23 Sep 2024 Annual General Meeting/Dividend - Re 1 Per Share 1.0000 —
22 Sep 2023 Annual General Meeting/Dividend - Re 1 Per Share 1.0000 —
22 Sep 2022 Annual General Meeting/Dividend - Rs 1.50 Per Share 1.5000 —

Board Meetings

View board meeting history →

Quarterly results, AGMs, buybacks and other board-approved business.

DatePurposeResults
20 Jul 2026 Financial Results Yes
8 May 2026 Financial Results/Dividend Yes
18 Mar 2026 Fund Raising —
16 Jan 2026 Financial Results Yes
17 Oct 2025 Financial Results Yes

Corporate Announcements

All 331 announcements, with search →

Exchange disclosures (NSE and BSE), most recent first.

DateCategoryAnnouncement
23 Sep 2026 Trading Window Bajaj Healthcare Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
22 Sep 2026 Shareholders meeting Bajaj Healthcare Limited has submitted the Exchange a copy Srutinizers report of Annual General Meeting held on September 21, 2026. Further, the company has informed the Exchange regarding voting results.
21 Sep 2026 Shareholders meeting Bajaj Healthcare Limited has informed the Exchange regarding Proceedings of Annual General Meeting held on September 21, 2026
21 Sep 2026 AGM/EGM Bajaj Healthcare Ltd - 539872 - Shareholder Meeting / Postal Ballot-Outcome of AGM
3 Sep 2026 Corp. Action Bajaj Healthcare Ltd - 539872 - Corporate Action-Record Date For Payment Of Final Dividend
3 Sep 2026 Record Date Bajaj Healthcare Limited has informed the Exchange that Record date for the purpose of Dividend is 14-Sep-2026.
30 Aug 2026 Copy of Newspaper Publication Bajaj Healthcare Limited has informed the Exchange about Copy of Newspaper Publication
29 Aug 2026 General Updates Bajaj Healthcare Limited has informed the Exchange regarding the Inland Letters sent to Shareholders
29 Aug 2026 General Updates Bajaj Healthcare Limited has informed the Exchange regarding Business Responsibility and Sustainability Report for the financial year 2025-26
29 Aug 2026 Shareholders meeting Bajaj Healthcare Limited has informed the Exchange regarding Notice of Annual General Meeting to be held on September 21, 2026

All announcements →

SWOT

Tradinity's own rule-based read of the real ratios elsewhere on this page -- not a copy of any third party's, and never a forward-looking prediction.

Strengths

  • Healthy liquidity (Current Ratio 1.78)

Weaknesses

  • Low Return on Equity (8.1%)
  • Thin net profit margin (2.3%)
  • Declining profit YoY (-79.4%)

Opportunities

Data unavailable.

Threats

  • PE above 35 (46.1) -- priced for continued strong execution
  • Down 31.9% over the past year

Board of directors and corporate information →

F&O

View F&O, Options & Backtest →

Data unavailable (no single-stock futures or options activity on record for this company).

Frequently asked questions about Bajaj Healthcare Limited

Where is the share price?

The price at the top of this page is the last traded price from exchange data; during market hours it refreshes on its own. The Chart & Technicals section has the full price history.

Where are the financial results?

The Financials page has quarterly and annual results, ratios, cash flow and the balance sheet, on a standalone or consolidated basis.

Who owns the company?

The Ownership section shows the latest shareholding pattern from exchange filings, with promoter, FII, DII and public holdings by quarter.

Does Tradinity give buy or sell advice?

No. The scores and checklist on this page are rule-based summaries of published figures, not recommendations. Tradinity is not a registered investment adviser.